Serum Leucine-Rich alpha2 Glycoprotein: A Novel Biomarker for Transmural Inflammation in Crohn's Disease. Takenaka K, Kitazume Y, Kawamoto A, Fujii T, et al. Am J Gastroenterol 2022 Dec 27. doi: 10.14309/ajg.0000000000002127.

Read + Share

Amedeo Smart

Independent Medical Education

Takenaka K, Kitazume Y, Kawamoto A, Fujii T, et al. Serum Leucine-Rich alpha2 Glycoprotein: A Novel Biomarker for Transmural Inflammation in Crohn's Disease. Am J Gastroenterol 2022 Dec 27. doi: 10.14309/ajg.0000000000002127.
PMID: 36571769